Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 2/20 | 0.52 |
| ▸ | ITGB3 | P05106 | 7/20 | 0.52 |
| ▸ | ITGAV | P06756 | 5/20 | 0.52 |
| ▸ | ITGA2B | P08514 | 5/20 | 0.52 |
| ▸ | ITGB6 | P18564 | 3/20 | 0.52 |
| ▸ | ITGB5 | P18084 | 2/20 | 0.52 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.48 |
| ▸ | ITGA5 | P08648 | 1/20 | 0.48 |
| ▸ | CTSA | P10619 | 2/20 | 0.41 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.41 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.41 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.41 |
| ▸ | BMP1 | P13497 | 2/20 | 0.40 |
| ▸ | PPARG | P37231 | 1/20 | 0.39 |
| ▸ | TAOK1 | Q7L7X3 | 1/20 | 0.39 |
| ▸ | TAOK3 | Q9H2K8 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6546018 | 1.00 | EPHX2 (0.52) | EPHX2ITGB3ITGAVITGA2BITGB6 | |
| Trifluoroacetic Acid SCHEMBL6811125 | 0.95 | ITGAV (0.55) | EPHX2ITGB3ITGAVITGA2BITGB6 | |
| Trifluoroacetic Acid SCHEMBL6806699 | 0.95 | ITGAV (0.55) | EPHX2ITGB3ITGAVITGA2BITGB6 | |
| SCHEMBL6545248 | 0.87 | ITGAV (0.52) | ITGB3ITGAVITGA2BITGB6ITGB5 | |
| SCHEMBL6806701 | 0.87 | EPHX2 (0.45) | EPHX2ITGB3ITGAVITGA2BITGB6 | |
| SCHEMBL6811127 | 0.87 | EPHX2 (0.45) | EPHX2ITGB3ITGAVITGA2BITGB6 | |
| SCHEMBL6545197 | 0.86 | ITGAV (0.57) | EPHX2ITGB3ITGAVITGA2BITGB6 | |
| SCHEMBL6545181 | 0.86 | ITGAV (0.57) | EPHX2ITGB3ITGAVITGA2BITGB6 | |
| SCHEMBL6546020 | 0.86 | ITGAV (0.57) | EPHX2ITGB3ITGAVITGA2BITGB6 | |
| SCHEMBL6805882 | 0.84 | ITGB3 (0.59) | ITGB3ITGAVITGA2BITGB6ITGB5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040142877-A1 | Ligands of the $g(a)v$g(b)6 integrin | MERCK PATENT GMBH (DE) | 2004-07-22 | — | — | US | claimed |
| EP-1379495-A2 | LIGANDS OF THE ALPHA-V-BETA 6 INTEGRIN | MERCK PATENT GmbH (DE) | 2004-01-14 | — | — | EP | claimed |
| WO-2002083627-A2 | LIGANDS DES INTEGRINS AVSS6 | MERCK PATENT GMBH (DE) | 2002-10-24 | — | — | WO | claimed |
| US-20040142877-A1 | Ligands of the $g(a)v$g(b)6 integrin | MERCK PATENT GMBH (DE) | 2004-07-22 | — | — | US | disclosed |
| EP-1379495-A2 | LIGANDS OF THE ALPHA-V-BETA 6 INTEGRIN | MERCK PATENT GmbH (DE) | 2004-01-14 | — | — | EP | disclosed |
| WO-2002083627-A2 | LIGANDS DES INTEGRINS AVSS6 | MERCK PATENT GMBH (DE) | 2002-10-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040142877-A1 | Ligands of the $g(a)v$g(b)6 integrin | ITGB6, ITGAV, ITGB1 | EPHX2 3198/4885ITGB3 13/4885ITGAV 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.